Skip to Content

Multikinase inhibitors

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Multikinase inhibitors work by inhibiting multiple intracellular and cell surface kinases, some of which are implicated in tumor growth and metastatic progression of cancer, thus decreasing tumor growth and replication. Multikinase inhibitors may be used to treat advanced kidney cancer as well as other specific types of cancer.

Filter by:
Drug Name DownUp( View by: Brand | Generic ) Reviews Ratings DownUp
dabrafenib systemic (Pro, More...)
1 review
   
9.0
trametinib systemic (Pro, More...)
1 review
   
9.0
crizotinib systemic (Pro, More...)
1 review
   
8.0
sunitinib systemic (Pro, More...)
14 reviews
   
7.7
sorafenib systemic (Pro, More...)
6 reviews
   
7.4
vemurafenib systemic (Pro, More...)
3 reviews
   
7.2
ibrutinib systemic (More...)
1 review
   
7.0
axitinib systemic (Pro, More...)
0 reviews
   
6.0
ruxolitinib systemic (Pro, More...)
1 review
   
5.0
ponatinib systemic (Pro, More...)
1 review
   
3.0
afatinib systemic (Pro, More...)
0 reviews
   
0.0
cabozantinib systemic (Pro, More...)
0 reviews
   
0.0
ceritinib systemic (Pro, More...)
0 reviews
   
0.0
idelalisib systemic (Pro, More...)
0 reviews
   
0.0
lenvatinib systemic (More...)
0 reviews
   
0.0
nintedanib systemic (More...)
0 reviews
   
0.0
palbociclib systemic (More...)
0 reviews
   
0.0
regorafenib systemic (Pro, More...)
0 reviews
   
0.0
vandetanib systemic (Pro, More...)
0 reviews
   
0.0
Hide